About Event

Thank you to our speakers, sponsors, and delegates who joined us in Berlin!

If you are interested in the 2024 event, please get in touch at info@hansonwade.com.

What's On?

The global success of mRNA medicines would not have succeeded without comprehensive analytical support. With more pressure on drug development timelines, the necessity to access novel, optimised and high-throughput analytical methods is paramount to guarantee the approval & commercialisation of safe and efficacious mRNA therapeutics and vaccines.

Industry experts navigated through case-study-led presentations and interactive discussions to:

Hot Sessions from 2023:

  • Maximise mRNA Characterisation to Ensure Safety, Efficacy & Quality of mRNA Therapeutics & Vaccines
  • Overcome Existing Potency & Quality Challenges with Advanced & Accurate Analytical Assays & Techniques
  • Understand Standards & Regulatory Requirements for the Analytical Development of mRNA Vaccines for a Rapid Approval

2023 Event in Numbers:

80+

Attendees

18+

World Class Speakers

1

Roundtable Discussion

1

Panel Discussion

6+

Hours of Dedicated Networking